Influenza A virus H1N1 vaccine (Novavax/Cadila)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameInfluenza A virus H1N1 vaccine (Novavax/Cadila)

Drug Alias NameSwine flu vaccine (Novavax/Cadila)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMexico

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovavax

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ07BB